You have to go back to the big announcement from 3 March 2014:...

You have to go back to the big announcement from 3 March 2014:

Optiscan deploys its latest endomicroscope system for gastroenterology at St Vincent’s Hospital, Sydney.
Optiscan is pleased to announce the successful commencement of a clinical study being undertaken by gastroenterologists and scientists from the Garvan Institute of Medical research and St Vincent's Hospital (Sydney Australia) in affiliation with the University of New South Wales (UNSW).
The study marks the introduction of Optiscan's second generation endomicroscopy platform
into the field gastroenterology.

Optiscan must have donated or lent a unit  to St Vinents in Sydney as no sales have been reported recently.
Hopefully it's the last of the freebies.
I'm dying to hear the results of the study.  Anyone know how to find out if this resulted in a paper?

On a more positive note: At the time of fund raising (June 15) it was anticipated that ...Optiscan’s second generation animal imaging system, CellLIVE, is expected to generate its first sales in the September quarter.

I really do believe revenues will from from about now. I just think the buggers will make us wait till the half year results to tell us. Our patience will be rewarded I'm sure.

And we will soon hear about a roadmap to production of the Zeiss product soon. Lot's of positive news in the pipeline.
I'm thirsty. I want to raise a toast to Wink's millionaire grandkids.  Wish it would speed up already.